Emory University President James Wagner has announced the appointment of Michael J. Mandl to the position of president and CEO of Emory Healthcare.
Mandl has served Emory University as executive vice president for business and administration since joining Emory in 2003. In this capacity, he has served on the Emory Healthcare Board of Directors, and was appointed chair in September 2014. He is also a member of the Board of the Emory Saint Joseph’s Joint Operating Company.
“Mike Mandl is a proven leader with extraordinary intellect, integrity, executive capacity, and great heart,” says Wagner. “He is the right leader at the right time for Emory Healthcare. As one of this nation’s premier academic medical centers, Emory Healthcare is uniquely positioned to help lead the way through our country’s rapidly evolving health care landscape. Mike deeply believes that value in the new world of health care will come via strong physician engagement and leadership going forward.”
“Emory Healthcare is very strong and well positioned to meet the challenges of the market going forward,” says Douglas Ivester, chair of the Robert W. Woodruff Health Sciences Board and a member of the Emory University Board of Trustees. “We have enjoyed the strong leadership of John Fox for the past 16 years, and Emory is indeed fortunate to have an exceptionally thoughtful and talented leader like Mike Mandl to assume the CEO position and know him to be fully committed to the mission and people of Emory Healthcare. Mike has an unwavering commitment to our patents and to Emory’s research and education missions.”
In his new role as president and CEO of Emory Healthcare, Mandl will serve one of the Southeast’s largest and most comprehensive health care systems. Emory Healthcare is composed of Emory University Hospital, Emory University Hospital Midtown, Emory University Orthopaedics & Spine Hospital, Emory University Hospital at Wesley Woods, Emory Saint Joseph’s Hospital, Emory Johns Creek Hospital, Emory Rehabilitation Hospital in Partnership with Select Medical, Emory Clinic, Emory Specialty Associates and the Emory Healthcare Network.
“It is an incredible privilege to serve Emory University in this role,” says Mandl. “I have worked in partnership with Emory’s senior leaders and trustees over the years exploring opportunities for positioning Emory Healthcare for continued success. I look forward to working closely with the leadership team at Emory Healthcare. I am grateful to have a seasoned, committed, passionate team of colleagues, advisors, and health care experts.”
Emory and WellStar Health System recently announced formal discussions regarding potentially combining Emory Healthcare and WellStar into a new, independent 501(c)(3) health care entity. Mandl, in close partnership with Emory’s Woodruff Health Sciences Center leadership, has led those discussions on behalf of Emory since their inception and will continue to do so.
“Mike’s vision, creativity, and strong ability to work in partnership with others will serve our university and Emory Healthcare’s physicians, nurses, staff, and most importantly, patients, very well,” says John Morgan, chair of Emory University’s Board of Trustees. “Mike brings a strong work ethic, unique sense of commitment, and a common sense approach to this important position.”
In addition to his role as an executive vice president overseeing the business areas of Emory, Mandl is also the board chair for Emory Innovations, Inc., which was created for innovative new enterprises including the Drug Innovation Venture (DRIVE), and of EmTech, Inc., an enterprise established in partnership with Georgia Tech. Since joining Emory, Mandl has also built strong ties throughout Metro Atlanta. He currently serves on the Executive Committee of the Board for the Midtown Alliance and has served the metro community through nonprofit board appointments, including the Metro YMCA and The Fernbank Museum.
Prior to Emory, Mandl served as a vice president at Duke Univversity and was a member of the senior leadership team, working closely with both university and health system executives and the board of trustees. He held other leadership positions at the University of Pennsylvania and Duke and, earlier in his career, worked at KPMG and Glaxo Pharmaceuticals. Mandl graduated with distinction from George Washington University. He earned a master’s degree in liberal studies from Duke University and held fellowships for doctoral work at Duke’s Fuqua School of Business and the University of Michigan Business School.
